Jefferies keeps Charles River at hold

Charles River Laboratories International, Inc. was maintained at hold a rating with a $50 price target by Jefferies & Co., Inc. analyst David Windley after the company reported non-GAAP earnings per share of $0.50, compared to the analyst's estimate of $0.61 and consensus of $0.57. Charles River had sales of $283.77 million, below Jefferies' estimate of $295.89 million and consensus of $293.14 million. Management adjusted its 2006 non-GAAP guidance to $2.12-$2.18 from $2.34-$2.40. Shares of the Wilmington, Mass., pharmaceutical company were down $7.26 or 15.48%, at $39.64 on volume of 4,999,300 shares versus the three-month running average of 409,732 shares. (NYSE: CRL)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.